You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Last Updated: February 24, 2020

DrugPatentWatch Database Preview

Finafloxacin - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for finafloxacin and what is the scope of patent protection?

Finafloxacin is the generic ingredient in one branded drug marketed by Merlion Pharms Gmbh and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Finafloxacin has thirty-nine patent family members in eighteen countries.

Summary for finafloxacin

International Patents:	39
US Patents:	3
Tradenames:	1
Applicants:	1
NDAs:	1
Bulk Api Vendors:	25
Clinical Trials:	7
Patent Applications:	16
DailyMed Link:	finafloxacin at DailyMed

Recent Clinical Trials for finafloxacin

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
MerLion Pharmaceuticals GmbH	Phase 2
MerLion Pharmaceuticals GmbH	Phase 1

See all finafloxacin clinical trials

Synonyms for finafloxacin

(-)-8-Cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo(3,4-b)-1,4-oxazin-6(2H)-yl)-4-oxo-1
(-)-8-Cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo(3,4-b)-1,4-oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
209342-40-5
3-Quinolinecarboxylic acid,8-cyano-1-cyclopropyl-6-fluoro-7-[(4as,7as)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-
7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid,hydrochloride
8-cyano-1-cyclopropyl-6-fluoro-7-((1S,6S)-2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
8-cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
AC-29291
AKOS027422437
BAY35-3377,finafloxacin hydrochloride
BCP23882
CHEBI:85176
CHEMBL1908370
CS-5557
D10575
D26OSN9Q4R
DB09047
DTXSID10175096
Finafloxacin (INN)
Finafloxacin [INN]
FYMHQCNFKNMJAV-HOTGVXAUSA-N
gastrochinolon
gastroquinolone
HY-13451
QCR-30
SB17124
SCHEMBL1002869
UNII-D26OSN9Q4R
Xtoro
Xtoro (TN)
Xtoro;7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
ZINC3985346

US Patents and Regulatory Information for finafloxacin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Merlion Pharms Gmbh	XTORO	finafloxacin	SUSPENSION/DROPS;OTIC	206307-001	Dec 17, 2014		DISCN	Yes	No	Start Trial	Start Trial				Start Trial
Merlion Pharms Gmbh	XTORO	finafloxacin	SUSPENSION/DROPS;OTIC	206307-001	Dec 17, 2014		DISCN	Yes	No	Start Trial	Start Trial				Start Trial
Merlion Pharms Gmbh	XTORO	finafloxacin	SUSPENSION/DROPS;OTIC	206307-001	Dec 17, 2014		DISCN	Yes	No	Start Trial	Start Trial				Start Trial
Merlion Pharms Gmbh	XTORO	finafloxacin	SUSPENSION/DROPS;OTIC	206307-001	Dec 17, 2014		DISCN	Yes	No	Start Trial	Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for finafloxacin

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merlion Pharms Gmbh	XTORO	finafloxacin	SUSPENSION/DROPS;OTIC	206307-001	Dec 17, 2014	Start Trial	Start Trial
Merlion Pharms Gmbh	XTORO	finafloxacin	SUSPENSION/DROPS;OTIC	206307-001	Dec 17, 2014	Start Trial	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for finafloxacin

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Korea	20150090045	Start Trial
South Korea	101541823	Start Trial
Japan	2016500079	Start Trial
Taiwan	201102395	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.